BE868033A - Nouveaux derives de w-pentaprostaglandines, substitues en position 15 - Google Patents

Nouveaux derives de w-pentaprostaglandines, substitues en position 15

Info

Publication number
BE868033A
BE868033A BE188496A BE188496A BE868033A BE 868033 A BE868033 A BE 868033A BE 188496 A BE188496 A BE 188496A BE 188496 A BE188496 A BE 188496A BE 868033 A BE868033 A BE 868033A
Authority
BE
Belgium
Prior art keywords
pentaprostaglandines
substitutes
new derivatives
derivatives
new
Prior art date
Application number
BE188496A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE868033A publication Critical patent/BE868033A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE188496A 1977-06-13 1978-06-12 Nouveaux derives de w-pentaprostaglandines, substitues en position 15 BE868033A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/805,879 US4404372A (en) 1977-06-13 1977-06-13 15-Substituted-ω-pentanorprostaglandin derivatives

Publications (1)

Publication Number Publication Date
BE868033A true BE868033A (fr) 1978-12-12

Family

ID=25192775

Family Applications (1)

Application Number Title Priority Date Filing Date
BE188496A BE868033A (fr) 1977-06-13 1978-06-12 Nouveaux derives de w-pentaprostaglandines, substitues en position 15

Country Status (11)

Country Link
US (1) US4404372A (fr)
JP (1) JPS581118B2 (fr)
BE (1) BE868033A (fr)
DE (1) DE2825855C3 (fr)
DK (1) DK262478A (fr)
FR (1) FR2394539A1 (fr)
GB (1) GB2000128B (fr)
IE (1) IE47626B1 (fr)
IT (1) IT1096628B (fr)
LU (1) LU79801A1 (fr)
NL (1) NL171892C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150279B (fr) * 1978-01-16 1982-09-04 Pfizer
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
US6476064B1 (en) 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
CN1639117A (zh) * 2002-03-01 2005-07-13 阿勒根公司 前列腺酰胺的制备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987087A (en) * 1971-07-29 1976-10-19 The Upjohn Company Phenyl-substituted prostaglandin-f type analogs
US3954741A (en) * 1972-06-07 1976-05-04 Pfizer Inc. N-substituted prostaglandin carboxamides
US3971826A (en) * 1972-07-13 1976-07-27 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
US3987085A (en) * 1972-09-15 1976-10-19 The Upjohn Company 8β,11β,12α-PGF2.sub.α compounds
US3984424A (en) * 1972-11-08 1976-10-05 Pfizer Inc. P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
IL50310A (en) * 1972-11-08 1977-08-31 Pfizer Dimethyl ketophosphonates
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins

Also Published As

Publication number Publication date
JPS545954A (en) 1979-01-17
US4404372A (en) 1983-09-13
NL7805378A (nl) 1978-12-15
IT7824472A0 (it) 1978-06-12
GB2000128B (en) 1982-02-03
IE47626B1 (en) 1984-05-16
DE2825855B2 (fr) 1980-11-06
DE2825855A1 (de) 1978-12-14
DK262478A (da) 1978-12-14
JPS581118B2 (ja) 1983-01-10
FR2394539A1 (fr) 1979-01-12
IE781181L (en) 1978-12-13
NL171892B (nl) 1983-01-03
NL171892C (nl) 1983-06-01
GB2000128A (en) 1979-01-04
FR2394539B1 (fr) 1980-10-24
LU79801A1 (fr) 1980-01-22
DE2825855C3 (de) 1981-10-08
IT1096628B (it) 1985-08-26

Similar Documents

Publication Publication Date Title
BE859912A (fr) Nouveaux derives de psoralene
BE851361A (fr) Nouveaux derives de proline et composes apparentes
FR2348926A1 (fr) Nouveaux derives de l'adenine
FR2319349A1 (fr) 4,5-dihydro-2-alcoxy inferieur-carbonylamino-4-phenylimidazoles et leurs derives phenyles substitues
FR2346356A1 (fr) Nouveaux derives de ((((2,4-dioxo-1-imidazolinyl) amino) carbonyl) amino) acetylcephalosporine
FR2319348A1 (fr) Derives de n-alkyl-imidazoles substitues
FR2332747A1 (fr) Derives d'a-aminocetones
MC1184A1 (fr) Derives d'oxadiazolopyrimidine
FR2322604A1 (fr) Derives 3-triazolylthio d'ureido-7a-methoxy-ou demethoxycephalosporines
BE850982A (fr) Halogenohydrates de derives n,n'-di substitues de la piperazine
MC1183A1 (fr) Derives d'oxadiazolopyrimidine
BE868033A (fr) Nouveaux derives de w-pentaprostaglandines, substitues en position 15
BE852457A (fr) Nouveaux derives 17-spirosultines
BE857639A (fr) Nouveaux derives de 5-thiazole alkylamine
BE850089A (fr) Nouveaux derives de l'hydrazine
BE852813A (fr) Derives de la nicotinoylaminotriazine
BE866933A (fr) Nouveaux derives de fortmicine
BE848694A (fr) Nouveaux composes de 2,1,3-benzothiadiazine substitues,
FR2303547A1 (fr) Derives de l'isoquinoleine
BE851503A (fr) Nouveaux derives de la 2-phenyl-2-hydroxyethylamine
FR2335220A1 (fr) Derives d'azetidinone
BE857284A (fr) Derives de l'azetidine
FR2346371A1 (fr) Nouveaux glucosides de 17 a-hydroxy-cardenolides
BE863608A (fr) Derives d'oxadiazolopyrimidine
FR2327766A1 (fr) Nouveaux derives du 7,7-dimethylnorbornane

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19870630